20 states file suit against pharmaceutical companies including Mylan

CONNECTICUT — Every state that shares a border with West Virginia has joined a lawsuit against Mylan Pharmaceuticals and drug companies claiming fraudulent pricing practices.

The suit, filed in Connecticut, says Mylan, TEVA and 4 other companies conspired and colluded to fix prices of generic drugs to pad profits.

According to Consumerist.com, “The lawsuit contends that whenever one of these companies would enter into the generics market for a certain drug, the group of defendants would allegedly conspire to determine how much of the market share each participant in the conspiracy would receive.”

The companies accused in the alleged price-fixing are Aurobindo Pharma USA, Citron Pharma, Heritage Pharmaceuticals, Mayne Pharma, Mylan Pharmaceuticals, and Teva Pharmaceuticals.

Attorneys general from Connecticut, Delaware, Florida, Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Nevada, New York, North Dakota, Ohio, Pennsylvania, Virginia and Washington filed the civil suit Thursday, December 15.